Better Health for All

Cullinan Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune diseases and various cancers, including non-small cell lung cancer, leukemia, and solid tumors.

Its entire product portfolio is dedicated to health improvement, with a stated culture centered on improving people's lives and making transformational changes for patients. The company's operations are stated to comply with environmental laws, rules, and regulations, indicating no significant health externalities. The company offers employee-led groups, an online learning platform, tuition reimbursement, a 401(K) plan with a 5% match, and contributes 90% to health and dental premiums and 100% to vision, disability, and life insurance. It also provides an Employee Assistance Program and gym reimbursement. The company collects, uses, shares, and processes personal information according to its privacy notice, implementing reasonable security measures and providing user rights to access, modify, export, or delete data. The company is dedicated to ensuring its clinical trials engage a full range of patients, and its Code of Conduct encourages reporting of suspected violations.

Fair Money & Economic Opportunity

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune diseases and cancer.

The company does not offer lending or deposit services, consumer credit products, or financial services to customers. Therefore, all KPIs related to financial products, pricing, fees, lending compliance, debt burden, and customer financial outcomes are not applicable. While the company engages in diversity, equity, and inclusion initiatives related to its employees and clinical trials, these do not pertain to financial inclusion or economic opportunity for external underserved communities through financial products as defined by this value.

Fair Pay & Worker Respect

The company has no explicitly mentioned regulatory actions, violations, fines, or compliance issues.

Cullinan Therapeutics contributes 90% of the premium for health and dental insurance, and 100% for vision, disability, and life insurance.

Kind to Animals

Cullinan Therapeutics conducts pre-clinical studies on animals to assess product safety.

However, no specific data is provided regarding the percentage of cruelty-free certified products, the extent of non-animal testing methods employed, the percentage of animal-related operations with humane certifications, the measurable impact of wildlife conservation initiatives, the percentage of animal-derived ingredients replaced with ethical alternatives, the percentage of animal-related suppliers audited for welfare compliance, the percentage of cage-free sourcing, the strength or scope of animal testing policies, the annual volume of animals used in testing, the percentage of R&D budget invested in animal-free technologies, the ethics of animal agriculture practices, participation in animal-free R&D collaborations, or public policy engagement related to animal welfare.

No War, No Weapons

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune diseases and cancer.

The provided articles do not contain any information indicating involvement in arms manufacturing, military contracts, or conflict facilitation. Therefore, all KPIs related to defense, arms, dual-use technology, or conflict-zone activities are marked as 'N/A – no defense or arms-related activities in core business' or 'N/A – no applicable technology development' or similar, as there is no evidence to suggest these activities are part of the company's operations.

Planet-Friendly Business

Cullinan Therapeutics, Inc. (CGEM.US) lacks publicly available data across all specified Planet-Friendly Business KPIs.

The provided articles explicitly state a lack of specific ESG metrics, including greenhouse gas emissions, renewable energy usage, water consumption, waste diversion, and climate targets. No specific regulatory actions, violations, fines, or compliance issues related to environmental performance are mentioned in the articles.

Respect for Cultures & Communities

The company has no reported cultural appropriation incidents.

While the company mentions general commitments to diversity, equity, and inclusion (DEI) and participation in a community fundraising event, the provided articles do not contain specific quantitative data or concrete actions related to other aspects of Respect for Cultures & Communities, such as formal partnerships, reinvestment percentages, or protocol implementations.

Safe & Smart Tech

The company states that third-party contracts prohibit the use or disclosure of personal information except in accordance with its Privacy Notice, and no incidents of unauthorized data use are reported.

Users can contact the company to request access, modification, export, or deletion of their personal information, withdraw consent for processing, manage cookie consent, and opt-out of sharing personal information for targeted advertising or analytics. The company aims to comply with legal and regulatory requirements, including Washington’s My Health My Data Act, Nevada’s Consumer Health Data Privacy Law, Connecticut’s Data Privacy Act, and other U.S. privacy laws, as well as GCP, GMP, GLP, HGR Regulations, and anti-bribery and anti-corruption laws. The company mentions regular, mandatory security training for employees. It also conducts vulnerability assessments and utilizes cybersecurity managed detection and response. The company states it collects information consistent with described purposes and retains personal information for the period required or allowed by applicable law, or as long as reasonably necessary.